BioCentury
ARTICLE | Company News

Evotec and Abivax partner to target infectious diseases

September 15, 2017 7:15 PM UTC

Evotec AG (Xetra:EVT) and Abivax S.A.S. (Euronext Paris:ABVX) partnered to discover and develop compounds to treat viral infectious including respiratory syncytial virus (RSV), influenza and dengue fever. Abivax will identify targets and use its antiviral platform to discover compounds. Evotec will optimize the candidates. Abivax retains all rights to IP. ...

BCIQ Company Profiles

Abivax S.A.

Evotec SE